Reason for request
Re-assessment of the actual benefit at the request of the Transparency
Clinical Benefit
Low |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
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
CM7Kr527NbbSKF0c